Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Filgrastim 4Etoposide 4Ifosfamide 3Cisplatin 3Carboplatin 3Bleomycin 3Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal amphotericin B 1Thiotepa 1Taxes 1Standard of Care 1Second-Look Surgery 1Respiratory Physiological Phenomena 1Reoperation 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Platinum 1Mesna 1Immunohistochemistry 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Embryonal × Reoperation × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡